3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Nivolumab
7
pembrolizumab
4
Ipilimumab
4
cemiplimab
3
relatlimab
2
Watchful Waiting
2
Standard of Care
2
Specimen Handling
2
Prednisone
2
Photochemotherapy
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
Dermoscopy
2
Cryotherapy
2
Carboplatin
2
vedolizumab
1
trametinib
1
toripalimab
1
tirbanibulin
1
sulforaphane
1
gadopiclenol
1
famitinib
1
decitabine and cedazuridine drug combination
1
daromun
1
calcipotriene
1
anlotinib
1
X-Rays
1
Vitamin D
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
vedolizumab
×
Dermatologic
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled